Skip to content

Precision motion / Technology in development

A new
frontier
in autism
therapy.

SeaKing Solace is developing precision motion technology for future autism therapy, combining controlled movement, physiological measurement, and software.

SeaKing Solace simulator chair conceptAn illustrative wave sequence combines surge, sway, heave, roll, and pitch in a three-second rhythm. Wave direction starts diagonally and rotates through 360 degrees every minute. The chair keeps its forward orientation above a stationary base and ramp. This is not a measured motion profile or an engineering simulation.
0.6 m reference wave / 3 s period
Motion reduced
Platform concept

Philanthropy · Investment · Sponsorship

Current status

Concepts and engineering design. Phase 1 planning.

Motion reduced

Research collaboration

Thomas Jefferson University

Signed Statement of Work

Dr. David J. Whellan

Principal Investigator

The Smith family aboard a boat in Annapolis in 2021
The Smith family, Annapolis, 2021.

The people behind the purpose

More than a cruise.
A place to belong.

Outside research use, our plan is to welcome families of children with special needs aboard for shared experiences and a stronger community.

It began with Parker.

Parker’s unusually calm and regulated response during time on the water inspired a question and a product vision. Could the relevant qualities of motion be characterized and translated into precise technology?

That personal experience motivates the mission. Scientific measurement and engineering give us a disciplined way to pursue it.

Read Parker’s story ↗

Be part of what
moves us forward.

Philanthropy

University-administered research support

Explore

Investment

Software, engineering and development

Explore

Sponsorship

Media and vessel sponsorship

Explore

The technology we intend to build

Precision motion technology for future autism therapy.

Our ambition is a new therapeutic technology category: a platform that can deliver defined motion, measure physiological responses, and use validated findings to inform individualized protocols.

Our platform vision brings controlled multidirectional motion, physiological monitoring, and software together.

We are developing precision motion-based therapeutic technology with the potential to transform autism intervention and expand treatment possibilities for neurological and autonomic conditions.

01 / Intended capability

Controlled motion

A multidirectional platform designed around measurable, reproducible stimulus parameters.

02 / Intended capability

Integrated measurement

Synchronized motion and physiological monitoring to characterize responses and guide development.

03 / Intended capability

Data-informed software

Calibration and protocol development grounded in measured evidence, with adaptive capabilities as a future objective.

Why measurement comes first

Measure the motion. Engineer the platform.

The next step: measure the motion and responses that will inform its engineering.

Engineering the simulator requires a measured understanding of the motion it is intended to deliver. The proposed Phase 1 study will characterize natural multidirectional motion on a vessel alongside physiological responses.

These measurements will inform motion parameters, hardware configuration, sensor synchronization, and control software. Starting with the natural-motion setting gives the development team a measured foundation for building and calibrating a precisely controlled, land-based system.

From design to clinical reality

The product is the destination. R&D builds the path.

Concepts and engineering design provide the starting point. Measurement, calibration, prototyping, and clinical validation are the work required to advance that vision.

  1. 01

    Physiological characterization

  2. 02

    Engineering calibration

  3. 03

    Prototype and protocol development

  4. 04

    Clinical validation

  5. 05

    Clinical translation and commercialization

Explore the full development roadmap →

The next development priority

Phase 1 SAIL study: measurement that informs the machine.

The proposed Phase 1 SAIL study is the data foundation for the product: characterize natural motion, synchronize physiological responses, and translate supported findings into software and engineering requirements.

INPUT

Quantified motion

Measure vessel movement and the motion actually received at each participant’s head.

RESPONSE

Synchronized physiology

Align cardiovascular, respiratory, ocular, and other candidate signals with the motion record.

DEVELOPMENT

Engineering decisions

Use reliable findings to inform motion parameters, sensing, software, and controlled delivery.

Questions about the program

Understand the work. Find your place in it.

What is SeaKing Solace developing?

SeaKing Solace is a medical technology development venture with autism as its primary mission. The intended land-based platform brings controlled multidirectional motion, physiological monitoring, and software together. Concepts and engineering design exist; the next step is research measurement to inform the product.

Explore the precision motion platform
Why does the research begin on a vessel?

The proposed Phase 1 SAIL study will characterize natural vessel motion and synchronized physiological responses in healthy adults. Measuring both provides the motion parameters and response data needed to inform simulator hardware, calibration, sensors, and control software.

Read the proposed Phase 1 study scope
What science informs the program?

Six scientific white papers examine vestibular motion sensing, vestibular-autonomic interactions, autonomic and vagal regulation, neuroplasticity, motion-rich interventions, and the SeaKing Solace hypothesis. The series connects published literature with the measurements and development questions the program will investigate.

Explore the six scientific reviews
How can I fund the work?

Choose the relationship that fits your contribution: philanthropy for university-administered research support, investment for product development and strategic partnerships, or sponsorship for Destination: Discovery media and vessel benefits.

Compare philanthropy, investment, and sponsorship

Three ways to take part

Fund the Work

Philanthropy, investment, and sponsorship offer three distinct ways to fund the program. Choose the relationship that fits you.

Philanthropy

Who it is for
Individuals, families, and foundations supporting medical research.
What the money does
Research support administered through Thomas Jefferson University, including defined SeaKing Solace study responsibilities through a subaward.
What you receive
The opportunity to support defined research objectives under confirmed university gift terms.
Explore Philanthropy

Investment

Who it is for
Investors, development-capital partners, and strategic industry partners.
What the money does
Development capital and expertise to advance software, engineering, and the intended product milestones.
What you receive
A potential investment or partnership relationship, with terms determined through diligence and definitive agreements.
Explore Investment

Sponsorship

Who it is for
Brands and organizations seeking a commercial media and vessel sponsorship relationship.
What the money does
Support for Destination: Discovery media, vessel visibility, and the documented journey.
What you receive
Defined commercial media and visibility benefits under the sponsorship arrangements.
Explore Sponsorship

Phase 1 planning budget

$4,740,636